Andales, Moneth Q.

HRN: 21-86-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
CEFUROXIME 1.5GM (VIAL)
09/15/2022
09/15/2022
IV
1.5 Gms
On Call To OR
LTCS
Waiting Final Action 
09/15/2022
CEFUROXIME 1.5GM (VIAL)
09/15/2022
09/21/2022
IV
1.5g
Q8
CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: